Friends of the AACR Young Scientist Award
Philadelphia's elite cause-driven gala, Party with a Purpose, selected the American Association for Cancer Research as its beneficiary beginning in 2016. Through this partnership, the newly established Friends of the American Association for Cancer Research Scientific Achievement Award will be presented annually to a deserving scientist who has made major contributions to the field of cancer research. The recipient of this award is then given the opportunity to select an early-career investigator to receive the Friends of the AACR Young Scientist Award, a $50,000 grant to support an innovative cancer research project.
2017 Recipient of the Friends of the AACR Scientific Achievement Award
Stephen C. Rubin, MD
Chief, Division of Gynecologic Oncology
Professor, Department of Surgical Oncology
Fox Chase Cancer Center
2017 Friends of the AACR Young Scientist Award
Gina Mantia-Smaldone, MD
Assistant Professor, Department of Surgical Oncology
Fox Chase Cancer Center
Scientific Statement of Research
Dr. Mantia-Smaldone's research has focused on the immunogenicity of ovarian cancers, including endometriosis-associated ovarian cancers as well as BRCA1 mutated ovarian cancers. Since joining the Fox Chase Cancer Center, she has also served as the principal investigator for several industry-sponsored, cooperative group and investigator-initiated trials exploring innovative therapies for women suffering from recurrent ovarian cancer and other gynecologic malignancies.
Her 2017 Friends of the AACR Foundation Young Scientist Award will help to support an investigator-initiated trial aimed at examining clinical and immune responses to a novel agent in women with recurrent ovarian cancers.
Gina Mantia-Smaldone, MD, graduated from SUNY Stony Brook School of
Medicine, where she was inducted into the Alpha Omega Alpha Honor Society, and completed
an OB/Gyn residency at the Magee-Womens Hospital of the University of
Pittsburgh Medical Center. She subsequently completed a postdoctoral fellowship
in ovarian cancer immunology at the Magee-Womens Research Institute of the
University of Pittsburgh followed by a gynecologic oncology fellowship at the
Hospital of the University of Pennsylvania. She is currently an assistant
professor at the Fox Chase Cancer Center where her research focuses on
translational and clinical research dedicated towards targeted therapeutics for
Acknowledgement of Support
Despite the best advances in chemotherapy and surgical management, we
are still in critical need of research to prevent and treat ovarian cancer. With
funding from this award, I hope to identify novel targets for therapy which
will improve the prognosis and quality of life for ovarian cancer patients.
Top of page